Literature DB >> 14607859

Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay.

Sanna Rosengren1, Gary S Firestein, David L Boyle.   

Abstract

We developed methods for measuring inflammatory biomarkers (cytokines, chemokines, and metalloproteinases) in synovial biopsy specimens from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Soluble extracts of synovial fragments were prepared with mild detergent and analyzed by enzyme-linked immunosorbent assay (ELISA) for interleukin 1beta (IL-1beta), IL-6, IL-8, tumor necrosis factor alpha (TNF-alpha), and matrix metalloproteinase 3. The optimal detergent was 0.1% Igepal CA-630, which interfered minimally with ELISA detection but extracted 80% of IL-6 from synovial tissue. Upon spiking, 81 to 107% of added biomarkers could be recovered. To determine within-tissue variability, multiple biopsy specimens from each RA synovial extract were analyzed individually. A resulting coefficient of variation of 35 to 62% indicated that six biopsy specimens per synovial extract would result in a sampling error of < or = 25%. Preliminary power analysis suggested that 8 to 15 patients per group would suffice to observe a threefold difference before and after treatment in a serial biopsy clinical study. The previously described significant differences in IL-1beta, IL-6, IL-8, and TNF-alpha levels between RA and OA could be detected, thereby validating the use of synovial extracts for biomarker analysis in arthritis. These methods allow monitoring of biomarker protein levels in synovial tissue and could potentially be applied to early-phase clinical trials to provide a preliminary estimate of drug efficacy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607859      PMCID: PMC262451          DOI: 10.1128/cdli.10.6.1002-1010.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

1.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis.

Authors:  G S Firestein; J M Alvaro-Gracia; R Maki; J M Alvaro-Garcia
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

2.  Synovial tissue macrophage as a source of the chemotactic cytokine IL-8.

Authors:  A E Koch; S L Kunkel; J C Burrows; H L Evanoff; G K Haines; R M Pope; R M Strieter
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

3.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

4.  Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.

Authors:  K L MacNaul; N Chartrain; M Lark; M J Tocci; N I Hutchinson
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  Synovial fluid concentration of five different cytokines in rheumatic diseases.

Authors:  C I Westacott; J T Whicher; I C Barnes; D Thompson; A J Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

8.  Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids.

Authors:  G S Firestein; M M Paine; B H Littman
Journal:  Arthritis Rheum       Date:  1991-09

9.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors:  T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal:  Arthritis Rheum       Date:  1988-08

10.  Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells.

Authors:  D DeMarco; S L Kunkel; R M Strieter; M Basha; R B Zurier
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

View more
  20 in total

1.  Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study.

Authors:  David L Boyle; Samuel E DePrimo; Cesar Calderon; Dion Chen; Paul J Dunford; William Barchuk; Gary S Firestein; Robin L Thurmond
Journal:  Inflamm Res       Date:  2019-02-09       Impact factor: 4.575

2.  Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.

Authors:  Chie Suzuki; Koji Yoshioka; Manabu Yamada; Toru Miyamoto; Noboru Manabe
Journal:  Vet Res Commun       Date:  2013-09-22       Impact factor: 2.459

3.  Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6.

Authors:  Monica Guma; Deepa Hammaker; Katharyn Topolewski; Maripat Corr; David L Boyle; Michael Karin; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2012-09

4.  Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease.

Authors:  Brigid S Boland; David L Boyle; William J Sandborn; Gary S Firestein; Barrett G Levesque; Joshua Hillman; Bing Zhang; James Proudfoot; Lars Eckmann; Peter B Ernst; Jesus Rivera-Nieves; Suresh Pola; Nedret Copur-Dahi; Guangyong Zou; John T Chang
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

5.  PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy.

Authors:  Lindsey N Jackson; Shawn D Larson; Scott R Silva; Piotr G Rychahou; L Andy Chen; Suimin Qiu; Srinivasan Rajaraman; B Mark Evers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

6.  Alternative medicine products as a novel treatment strategy for inflammatory bowel disease.

Authors:  Lindsey N Jackson; Yuning Zhou; Suimin Qiu; Qingding Wang; B Mark Evers
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

7.  BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters.

Authors:  Ola Grimsholm; Solbritt Rantapää-Dahlqvist; Tore Dalén; Sture Forsgren
Journal:  Clin Rheumatol       Date:  2008-05-17       Impact factor: 2.980

8.  An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype.

Authors:  John W Whitaker; Robert Shoemaker; David L Boyle; Josh Hillman; David Anderson; Wei Wang; Gary S Firestein
Journal:  Genome Med       Date:  2013-04-30       Impact factor: 11.117

9.  The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.

Authors:  Marina Stolina; Brad Bolon; Scot Middleton; Denise Dwyer; Heather Brown; Diane Duryea; Li Zhu; Alison Rohner; James Pretorius; Paul Kostenuik; Ulrich Feige; Debra Zack
Journal:  J Clin Immunol       Date:  2008-08-26       Impact factor: 8.317

10.  Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis.

Authors:  Catherine A Brissette; Heidi M Houdek; Angela M Floden; Thad A Rosenberger
Journal:  J Neuroinflammation       Date:  2012-11-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.